Skip to main content
Premium Trial:

Request an Annual Quote

Lark Technologies Sets Date for Vote on Acquisition by Genaissance

NEW YORK, Feb. 20 (GenomeWeb News) - Lark Technologies will hold a vote of its stockholders to decide on the proposed acquisition by Genaissance Pharmaceuticals on April 1, the company said today.

 

New Haven, Conn.-based Genaissance announced its plan to acquire Lark, based in Houston, in December.

The all-stock transaction is valued at approximately $19.9 million, based on the closing price of Genaissance's common stock of $2.99 per share on Dec. 18, 2003.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.